SAN ANTONIO — Mission Pharmacal Co. has sold a half-dozen over-the-counter health products under the Dr. Smith’s and Thera-Gesic brands to MainPointe Pharmaceuticals LLC.
With the divestitures, Mission also licensed the marketing rights for five other OTC health products to Louisville, Ky.-based Mainpointe.
The products sold include Thera-Gesic and Thera-Gesic Plus pain relieving creme, Dr. Smith’s Diaper Rash Ointment, Dr. Smith’s Diaper Rash Spray, Dr. Smith’s Adult Ointment and Dr. Smith’s Adult Barrier Spray (for incontinence-associated dermatitis).
MainPointe gained marketing rights for Calcet (a calcium supplement), Fosfree (a calcium, vitamin and iron supplement), Heat Guard (a sodium and potassium chloride supplement), Maxilube (a personal lubricant) and the Lycelle Head Lice Removal Kit (a pesticide-free, head lice treatment).
Along with the product transactions, Mission and MainPointe have entered into a renewable contract manufacturing agreement to continue production all of the products now made at Mission’s manufacturing facility.
The companies noted that the agreements don’t involve the marketing or manufacturing of any of Mission’s branded prescription medicines.
“These are exciting agreements that will provide consumers greater access to the products involved due to MainPointe’s existing relationships within more diverse distribution channels,” stated Mission Pharmacal president Neill Walsdorf. “Mission remains passionate about the products involved and, more importantly, we are steadfast in our support of the end users who rely on these products every day.”
Beyond its core pharmaceutical business, Mission Pharmacal is the parent company of the Mission Family of Companies, a group of wholly owned subsidiaries that function independently, with products and services that can be scaled to provide customized solutions for business partners. Mission said that, specific to the MainPointe agreements, BexR Logistix LLC and its subsidiary EPIC Fulfillment Inc. have the infrastructure in place to provide warehousing and fulfillment. Alamo Pharma Services Inc. also is positioned to provide sales support and salesforce training.
“We look at these agreements as the beginning of an exciting strategic partnership between Mission and MainPointe,” Walsdorf added. “Our industry is continually evolving, and we hold strong to the belief that partnering for success is more essential today than ever before.”
MainPointe’s product portfolio includes the Slo-Niacin and Nexafed brands. Slo-Niacin is a niacin dietary supplement used to help improve heart health and control high cholesterol. Nexafed, which includes nasal decongestant and sinus pressure/pain relief products, is an OTC pseudoephedrine medication with proprietary technology to disrupt conversion to methamphetamine.